How much does the NHS spend on obesity?

Ready to take the next step? See if you're eligible for expert-led weight loss support.

Check your eligibility

As one of the UK's biggest health challenges, obesity comes at a great cost to the NHS and others. Learn the true cost of obesity in the UK.



As one of the UK's biggest health challenges, obesity comes at a great cost to the NHS and others. Learn the true cost of obesity in the UK.

Obesity is often described as one of the biggest health challenges facing the UK today. The obesity rate has almost doubled since 1993, when it stood at 14.9%. It affects millions and places a huge financial strain on the healthcare system.


With that in mind, how much does the NHS spend on obesity each year? And what is the wider cost to society? Let's find out.


How much money does the NHS spend on treating obesity?

It's estimated that the NHS will spend £9.3 billion on treating obesity-related illnesses in 2025, according to a joint study by Nesta and Frontier Economics. Those health problems include type 2 diabetes, heart disease, high blood pressure and certain types of cancers.


If you add the cost of health problems from being overweight, this figure jumps to an estimated £12.6 billion.


The true cost of obesity

When someone develops health issues linked to obesity, it's not just a question of how much obesity costs the healthcare system. Those costs ripple outwards to other service providers and other corners of society.


Social care costs

People living with obesity are more likely to require some sort of formal social care, whether that's:


  • Carers coming to their house to help them with daily tasks
  • Emotional and mental health support
  • Adaptations to their homes, such as stair lifts or accessible bathing
  • Medication management

Nesta's report estimated that formal social care for people living with obesity could cost local authorities £1 billion in 2025.



But that's not the only type of social care that puts a financial strain on society. When family members and friends step in to provide support ('informal social care'), that comes at a cost, too.


Picture of someone knocking on a door.

After all, those informal carers are spending time caring for loved ones for free. That's a very nice thing to do, but it means they're using up time when they could have been earning money or spending on leisure.


The report estimates that these informal social care arrangements could cost society £9.3 billion in 2025.


Lost productivity at work

Obesity and the health problems it can come with can affect people in their place of work. This can have a knock-on effect on the economy to the tune of an estimated £23.8 billion in 2025. Here's how.

Unemployment

People living with obesity are less likely to be employed than those at a healthy weight. One study of more than 17,000 working-age adults in England found that, compared to healthy-weight individuals, employment was:


  • 21% lower in females living with obesity
  • 8.4% lower in males living with obesity

However, it's important to note that factors that aren't always observable to the researcher, such as socioeconomic background, may influence these statistics.


Time off work (presenteeism)

This includes sick days and days off work to attend health appointments, for example.


Workers living with class III obesity (a BMI of 40+) account for more than 40% of presenteeism costs (£3.9 billion out of £9.7 billion). However, they only represent 13% of the workforce with obesity.


Reduced productivity at work

Living with obesity can also influence factors like the quality and quantity of a person's work.  For instance, if a person with obesity develops sleep apnoea, it may cause tiredness. In turn, this can make it difficult to concentrate during the working day.


So, as you can see, the cost of obesity goes further than NHS spending. It can affect people's careers and well-being, too.

SemaPen is a weight loss clinic founded by UK obesity experts. As part of Phoenix Health, we've helped people lose weight for more than 20 years.


Sources

1. House of Commons Library (2025) Research briefing: Obesity statistics. Retrieved from https://commonslibrary.parliament.uk/research-briefings/sn03336/


2. Nesta (2025) The economic and productivity costs of obesity and overweight in the UK. Retrieved from https://media.nesta.org.uk/documents/The_economic_and_productivity_costs_of_obesity_and_overweight_in_the_UK_.pdf

This article was reviewed and approved by Lujain Alhassan, Bariatric Nutritionist, on 31 October 2025.


  • Average 15-21% weight loss*
  • Tailored programmes built by real experts
  • Targeted support to make success feel simpler
  • Unique app with weight loss tools and lessons

Your journey starts here

Start your personalised weight loss plan in minutes.

1

Start your online consultation

2

Get approved by our clinical team

3

Begin your programme

Get started
While Wegovy and Mounjaro cause some muscle loss, there are as many myths as facts floating around.
by Simon Edward 25 May 2026
While Wegovy and Mounjaro cause some muscle loss, there are as many myths as facts floating around. Learn what one medical doctor has to say.
Discover what HDL cholesterol is, why it's considered 'good',
by Simon Edward 22 May 2026
Discover what HDL cholesterol is, why it's considered 'good', and how healthy lifestyle changes can support heart health.
How does metabolism influence weight loss? Learn about metabolic rate, calorie balance
by Simon Edward 18 May 2026
How does metabolism influence weight loss? Learn about metabolic rate, calorie balance and how to support your metabolism effectively.
Learn what foods to avoid and what to focus on with Mounjaro and Wegovy, including tips to support
by Simon Edward 15 May 2026
Learn what foods to avoid and what to focus on with Mounjaro and Wegovy, including tips to support safe, sustainable results.
The NHS has announced that 1.2 million more patients in England will be eligible for semaglutide
by Simon Edward 11 May 2026
The NHS has announced that 1.2 million more patients in England will be eligible for semaglutide by summer. Learn the facts behind the headline.
A new study suggests GLP-1 drugs like Mounjaro may improve asthma symptoms
by Simon Edward 8 May 2026
A new study suggests GLP-1 drugs like Mounjaro may improve asthma symptoms for those living with obesity. Join us as we unpack the results.
Wegovy patents are expiring in some parts of the world.
by Simon Edward 1 May 2026
Wegovy patents are expiring in some parts of the world. Does that mean we'll soon see cheaper generic versions in the UK?
In 2025, Novo Nordisk announced disappointing results from its semaglutide Alzheimer's trial.
by Simon Edward 1 May 2026
In 2025, Novo Nordisk announced disappointing results from its semaglutide Alzheimer's trial. But that's not the end of the story. Find out why.
Have you been told you're ineligible for weight loss drugs? Learn about your options and your rights
by Simon Edward 1 May 2026
Have you been told you're ineligible for weight loss drugs? Learn about your options and your rights, including asking for a second opinion on the NHS.
What's the safest way to dispose of weight loss pens and needles? Learn proper disposal methods
by Simon Edward 1 May 2026
What's the safest way to dispose of weight loss pens and needles? Learn proper disposal methods for Mounjaro and Wegovy in our UK guide.
More posts